The new guidelines, published in the Journal of the American Academy of Dermatology (JAAD), will guide dermatologists in deciding the best possible prevention and treatment options for pediatric ...

Experts discuss the recent FDA approval of topical JAK inhibitors for children 2 years or older as a promising advancement in pediatric atopic dermatitis treatment, highlighting their efficacy, their ...

Experts discuss the central role of patient education and the strategic use of topical therapies in managing atopic dermatitis (AD), emphasizing the need for clear communication, age-appropriate ...

Global assessment and itch/scratch scores highlight the effectiveness of topical roflumilast for treating atopic dermatitis in children 3 months to 2 years old, in a phase 2 study.

For children with atopic dermatitis (AD), dupilumab treatment restores skin barrier function, according to a study published online Jan. 26 in the Annals of All ...

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a ...

Children with vs without active AD in Denmark had a similar prevalence of nonpassing grades (12.0% vs 11.2%; adjusted ...

Credit: Getty Images. The INTEGUMENT-PED trial included 652 children 2 to 5 years of age with mild to moderate atopic dermatitis who had a mean BSA of 22% and a range from 3% to 82%. A phase 3 trial ...

Please provide your email address to receive an email when new articles are posted on . Patients with moderate or severe disease reported more itch and pain than those with mild disease. Those with ...

A review in the Archives of Dermatological Research focuses on the similarities and differences between psoriasis and atopic dermatitis (AD) in pediatric patients. The authors note that distinguishing ...

In this video, Kristin Sokol, MD, MPH, FAAAAI, FACAAI, discusses the impact of atopic dermatitis on patients' quality of life.

A population-based UK cohort study found that children and adolescents with atopic dermatitis (AD), even those with more severe or persistent disease, did not show increased markers ...